Investment Director
Dr. Loretta Tse joined abrdn in October 2023 from Tekla Capital Management where she was a vice president investing in venture since 2015. Previously, Loretta ran a biotech consulting business and worked with various venture funds and start-up companies. Prior to that, she was Managing Director, Technology Transfer and Industry Relations at Fred Hutchinson Cancer Research Center, where she ran an office that was responsible for protection and commercialization of research output and formation of start-up companies. Loretta has also served as an associate at Oxford Biosciences Partners, an early-stage life science venture fund, and worked in business development at several early-stage biotech companies prior to joining Oxford. She holds a Ph.D. in pharmacology from Johns Hopkins School of Medicine and a B.S. in biochemistry from University of California, Davis.
Loretta has invested in over 20 life sciences companies and is currently on the BOD of CuraSen and HotSpot Therapeutics.